Faculty Appointments
Associate Professor of Pathology, Microbiology and Immunology
Education
Ph.D., Medicine and Pharmacology, Duke University, Durham, North CarolinaM.D., Medicine, Duke University, Durham, North CarolinaA.B., Biological Anthropology, Harvard University, Cambridge, Massachusetts
Office Address
Vanderbilt University Medical Center
1301 Medical Center Drive
4603A TVC
Nashville, TN 37232
1301 Medical Center Drive
4603A TVC
Nashville, TN 37232
Research Description
Impact of genetic changes on disease phenotype, prognosis, and response to therapy in myeloid malignancies
Publications
Ginnaram SR, Mason EF, Reddy NM. Durable Long-Term Response in a Patient With Diffuse Large B-Cell Lymphoma Treated With Nivolumab. Clin Lymphoma Myeloma Leuk [print-electronic]. 2020 Jul 7/22/2020; PMID: 32778514, PII: S2152-2650(20)30368-2, DOI: 10.1016/j.clml.2020.07.007, ISSN: 2152-2669.
Linnik Y, Pastakia D, Dryden I, Head DR, Mason EF. Primary central nervous system erythroid sarcoma with NFIA-CBFA2T3 translocation: a rare but distinct clinicopathologic entity [letter]. Am. J. Hematol [print-electronic]. 2020 Jul 7/22/2020; PMID: 32697373, DOI: 10.1002/ajh.25944, ISSN: 1096-8652.
Patel SS, Lipschitz M, Pinkus GS, Weirather JL, Pozdnyakova O, Mason EF, Inghirami G, Hasserjian RP, Rodig SJ, Weinberg OK. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Mod. Pathol [print-electronic]. 2020 Jul; 33(7): 1380-8. PMID: 32051557, PII: 10.1038/s41379-020-0498-z, DOI: 10.1038/s41379-020-0498-z, ISSN: 1530-0285.
Turner SA, Shaver AC, Kovach AE, Oluwole OO, Mason EF. Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome. Leuk. Lymphoma [print-electronic]. 2019 Dec; 60(13): 3312-5. PMID: 31230491, DOI: 10.1080/10428194.2019.1630619, ISSN: 1029-2403.
Mason EF, Hasserjian RP, Aggarwal N, Seegmiller AC, Pozdnyakova O. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. Blood Adv. 2019 Nov 11/12/2019; 3(21): 3322-32. PMID: 31698462, PMCID: PMC6855116, PII: 422695, DOI: 10.1182/bloodadvances.2019000328, ISSN: 2473-9537.
Patel SS, Ho C, Ptashkin RN, Sadigh S, Bagg A, Geyer JT, Xu ML, Prebet T, Mason EF, Seegmiller AC, Morgan EA, Steensma DP, Winer ES, Wong WJ, Hasserjian RP, Weinberg OK. Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms. Blood Adv. 2019 May 5/14/2019; 3(9): 1540-5. PMID: 31085507, PMCID: PMC6517660, PII: bloodadvances.2019000090, DOI: 10.1182/bloodadvances.2019000090, ISSN: 2473-9537.
Mason EF, Kuo FC, Hasserjian RP, Seegmiller AC, Pozdnyakova O. A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome. Am. J. Hematol [print-electronic]. 2018 Aug; 93(4): 504-10. PMID: 29274134, DOI: 10.1002/ajh.25018, ISSN: 1096-8652.
Mason EF, Pozdnyakova O, Li B, Dudley G, Dorfman DM. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders. Am. J. Clin. Pathol. 2017 Jul 7/1/2017; 148(1): 33-41. PMID: 28575142, PII: 3860185, DOI: 10.1093/ajcp/aqx041, ISSN: 1943-7722.
Mason EF, Morgan EA, Pinkus GS, Pozdnyakova O. Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data. Int J Lab Hematol [print-electronic]. 2017 Apr; 39(2): 137-46. PMID: 28133951, DOI: 10.1111/ijlh.12595, ISSN: 1751-553X.
Mason EF, Brown RD, Szeto DP, Gibson CJ, Jia Y, Garcia EP, Jacobson CA, Dal Cin P, Kuo FC, Pinkus GS, Lindeman NI, Sholl LM, Aster JC, Morgan EA. Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leuk. Lymphoma [print-electronic]. 2017 Jan; 58(1): 233-6. PMID: 27241017, DOI: 10.1080/10428194.2016.1185786, ISSN: 1029-2403.
Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS ONE [electronic-print]. 2013; 8(6): e67306. PMID: 23825651, PMCID: PMC3688991, PII: PONE-D-13-13213, DOI: 10.1371/journal.pone.0067306, ISSN: 1932-6203.
Linnik Y, Pastakia D, Dryden I, Head DR, Mason EF. Primary central nervous system erythroid sarcoma with NFIA-CBFA2T3 translocation: a rare but distinct clinicopathologic entity [letter]. Am. J. Hematol [print-electronic]. 2020 Jul 7/22/2020; PMID: 32697373, DOI: 10.1002/ajh.25944, ISSN: 1096-8652.
Patel SS, Lipschitz M, Pinkus GS, Weirather JL, Pozdnyakova O, Mason EF, Inghirami G, Hasserjian RP, Rodig SJ, Weinberg OK. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Mod. Pathol [print-electronic]. 2020 Jul; 33(7): 1380-8. PMID: 32051557, PII: 10.1038/s41379-020-0498-z, DOI: 10.1038/s41379-020-0498-z, ISSN: 1530-0285.
Turner SA, Shaver AC, Kovach AE, Oluwole OO, Mason EF. Myelodysplastic/myeloproliferative neoplasm with eosinophilia as a manifestation of Li Fraumeni Syndrome. Leuk. Lymphoma [print-electronic]. 2019 Dec; 60(13): 3312-5. PMID: 31230491, DOI: 10.1080/10428194.2019.1630619, ISSN: 1029-2403.
Mason EF, Hasserjian RP, Aggarwal N, Seegmiller AC, Pozdnyakova O. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. Blood Adv. 2019 Nov 11/12/2019; 3(21): 3322-32. PMID: 31698462, PMCID: PMC6855116, PII: 422695, DOI: 10.1182/bloodadvances.2019000328, ISSN: 2473-9537.
Patel SS, Ho C, Ptashkin RN, Sadigh S, Bagg A, Geyer JT, Xu ML, Prebet T, Mason EF, Seegmiller AC, Morgan EA, Steensma DP, Winer ES, Wong WJ, Hasserjian RP, Weinberg OK. Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms. Blood Adv. 2019 May 5/14/2019; 3(9): 1540-5. PMID: 31085507, PMCID: PMC6517660, PII: bloodadvances.2019000090, DOI: 10.1182/bloodadvances.2019000090, ISSN: 2473-9537.
Mason EF, Kuo FC, Hasserjian RP, Seegmiller AC, Pozdnyakova O. A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome. Am. J. Hematol [print-electronic]. 2018 Aug; 93(4): 504-10. PMID: 29274134, DOI: 10.1002/ajh.25018, ISSN: 1096-8652.
Mason EF, Pozdnyakova O, Li B, Dudley G, Dorfman DM. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders. Am. J. Clin. Pathol. 2017 Jul 7/1/2017; 148(1): 33-41. PMID: 28575142, PII: 3860185, DOI: 10.1093/ajcp/aqx041, ISSN: 1943-7722.
Mason EF, Morgan EA, Pinkus GS, Pozdnyakova O. Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data. Int J Lab Hematol [print-electronic]. 2017 Apr; 39(2): 137-46. PMID: 28133951, DOI: 10.1111/ijlh.12595, ISSN: 1751-553X.
Mason EF, Brown RD, Szeto DP, Gibson CJ, Jia Y, Garcia EP, Jacobson CA, Dal Cin P, Kuo FC, Pinkus GS, Lindeman NI, Sholl LM, Aster JC, Morgan EA. Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leuk. Lymphoma [print-electronic]. 2017 Jan; 58(1): 233-6. PMID: 27241017, DOI: 10.1080/10428194.2016.1185786, ISSN: 1029-2403.
Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS ONE [electronic-print]. 2013; 8(6): e67306. PMID: 23825651, PMCID: PMC3688991, PII: PONE-D-13-13213, DOI: 10.1371/journal.pone.0067306, ISSN: 1932-6203.